By Gina Shaw
The top five most costly drugs to Medicaid currently include three specialty medications, all antivirals and all manufactured by Gilead: the hepatitis C drugs sofosbuvir (Sovaldi) and ledipasvir-sofosbuvir (Harvoni), and the HIV combination therapy tenofovir disoproxil-emtricitabine (Truvada), according to a new issue brief released by the Kaiser Family Foundation.
Specialty drugs represent 34% of the 50 most costly drugs to Medicaid, but only 6% of Medicaid outpatient drugs
AUGUST 2, 2016